Loading resource…
American Society of Clinical Oncology
The ASCO Guidelines offer recommendations that are derived from a thorough analysis of existing studies and literature concerning neoadjuvant chemotherapy for advanced ovarian cancer. These guidelines are intended for voluntary use by clinicians and are not definitive treatment protocols. They emphasize the importance of independent clinical judgment in applying the recommendations to individual patient scenarios. The document also discusses the role of surgical intervention and the assessment of tumor burden in guiding therapy decisions.
No account needed